Abstract:Abstract Atopic dermatitis (AD) is a common, relapsing–remitting inflammatory skin disease that is associated with other disorders such as food allergy, allergic asthma and rhinitis, leading to increased rates of morbidity and mortality. The discovery of CD1a involvement in AD pathogenesis through the presentation of permissive neolipid antigens generated by house dust mite phospholipase A2 (PLA2) enhanced our understanding of the complex network of T-cell targets that contribute to disease development. As well as defining agonist lipids, it is now known that very long-chain sphingomyelins can act as natural lipid antagonists of CD1a–T-cell receptor (TCR) engagement. We sought to determine whether bacterial sphingomyelinases (SMases) could also activate CD1a-reactive T cells and help explain the known bacterial infection-associated manifestations of AD. An isoelectric focusing system was used to evaluate the hydrolytic capacity of bacterial SMases on very long-chain CD1a-preferred sphingomyelins. Additionally, this approach permitted examination of the impact of cobalt and nickel ions on bacterial SMase activity. Furthermore, using primary human T-cell clones and TCR transfer with CRISPR Homology Directed Repair, we evaluated SMase-reactive CD1a-dependent T-cell responses. Moreover, we examined both lesional and nonlesional skin from patients with AD, patients with psoriasis and healthy controls using RNA-Seq. Bacterial SMases were able to digest CD1a-selected sphingomyelins, and the enzymatic activity was potentiated by the presence of divalent metal ions, which are known contact dermatitis allergens. Furthermore, bacterial SMase-reactive CD1a-dependent T-cell responses were identified through markedly increased detection of AD-associated inflammatory cytokines and elevated activation marker expression. Consistency of responses between the primary T-cell clones and HDR T cells confirmed that these responses were indeed TCR specific. Skin transcriptomic changes included altered lipid processing pathways, in particular, mammalian SMase and PLA2-mediated pathways, activated in lesional tissue. We showed that bacterial SMases can effectively degrade very long-chain antagonist sphingomyelins and potentiate CD1a-reactive T-cell responses. In addition, our bioinformatics analysis revealed enhanced expression of mammalian SMases in lesional AD and psoriasis, suggesting potential broad involvement of this enzyme class in skin inflammation. This study extends our understanding of the role of lipid-metabolizing enzymes to CD1a-dependent T-cell activation in AD pathology, as well as defining a hitherto unknown pathway of contact dermatitis. The mechanisms provide insights towards novel targets for therapeutic intervention. The principal investigator has received relevant research collaboration support from UCB and Janssen. The principal investigator and some members of the group are on patents filed on CD1a.

The deubiquitinating enzyme CYLD impairs NF-κB- and STAT1-dependent macrophage intrinsic immunity to Staphylococcus aureus

The SYK side of TLR4: signalling mechanisms in response to LPS and minimally oxidized LDL

A pro-inflammatory role of deubiquitinating enzyme cylindromatosis (CYLD) in vascular smooth muscle cells.

Macrophage Autophagy Deficiency-Induced CEBPB Accumulation Alleviates Atopic Dermatitis Via Impairing M2 Polarization

Cyld restrains the hyperactivation of synovial fibroblasts in inflammatory arthritis by regulating the TAK1/IKK2 signaling axis

Constitutive expression of the deubiquitinating enzyme CYLD does not affect microglia phenotype or function in homeostasis and neuroinflammation

Deubiquitinating Enzyme CYLD Negatively Regulates the Ubiquitin-Dependent Kinase Tak1 and Prevents Abnormal T Cell Responses

Cylindromatosis (CYLD), a Deubiquitinase, Attenuates Inflammatory Signaling Pathways by Activating Toll-Like Receptor 3 in Human Mesangial Cells

NLRP3 Inhibition Ameliorates Severe Cutaneous Autoimmune Manifestations in a Mouse Model of Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy–Like Disease

The Essential Role of Peptidylarginine Deiminases 2 for Cytokines Secretion, Apoptosis, and Cell Adhesion in Macrophage

Ddb1-Cullin4-Associated-Factor 1 in Macrophages Restricts the Staphylococcus Aureus-Induced Osteomyelitis.

Cyld Deubiquitinates Rip1 In The Tnf Alpha-Induced Necrosome To Facilitate Kinase Activation And Programmed Necrosis

CYLD Deubiquitinates Nicotinamide Adenine Dinucleotide Phosphate Oxidase 4 Contributing to Adventitial Remodeling

The Deubiquitinase CYLD Controls Protective Immunity Against Helminth Infection by Regulation of Treg Cell Plasticity.

CD15 The role of lipid-metabolizing enzymes in CD1a-associated cutaneous inflammation

Interferon-Lambda 1 Inhibits Staphylococcus aureus Colonization in Human Primary Keratinocytes

MyD88-dependent signaling influences fibrosis and alternative macrophage activation during Staphylococcus aureus biofilm infection

An emerging role of deubiquitinating enzyme cylindromatosis (CYLD) in the tubulointerstitial inflammation of IgA nephropathy.

Staphylococcus aureus exacerbates dermal IL-33-ILC2 axis activation through evoking RIPK3/MLKL-mediated necroptosis of dry skin

Macrophage acetyl-CoA carboxylase regulates acute inflammation through control of glucose and lipid metabolism

Syk-MyD88 Axis Is a Critical Determinant of Inflammatory-Response in Activated Macrophages